Senate HELP Committee Passes User Fee Package

US FDA user fees took another step toward renewal Tuesday as the Senate’s Committee on Health, Education, Labor and Pensions (HELP) voted to support the bill along with other health-related issues.

A United States Senate committee hearing room in Washington, DC.
• Source: Shutterstock

It was a long road for the Medical Device User Fee Amendments, also known as MDUFA V, this time around. Thanks to pandemic-related delays, the US Food and Drug Administration and medtech industry didn’t even start their negotiations until about a year after what was originally planned. And then talks dragged on as the sides bickered. By the time a draft commitment letter made it to Congress, the statutory deadline was two months past.

But things have been moving a lot more smoothly since lawmakers took up user fee legislation. The House of Representatives passed the legislative package on 8 June. And six...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By 

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

‘Help Us Deregulate’: RFK Announces RFI For Trimming Government Health Agencies

 

HHS Secretary Robert F. Kennedy, Jr. is asking the public to help cut waste across the government’s health agencies. Kennedy announced a 60-day comment period allowing the public to take part in a broader federal initiative to reduce regulations and increase transparency.

MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains

 

The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.

More from Policy & Regulation